TJAB Forms Drug Development JV with Antisense of Australia
03:35 EDT 20 Jul 2012 | ChinaBio Today
Tianjin International Joint Academy of Biotechnology and Medicine (TJAB) has formed a JV with Antisense Technologies of Australia to develop a drug discovered by ANB. The drug, ATL1102, is aimed at multiple sclerosis, stem cell mobilization and as..
Original Article: TJAB Forms Drug Development JV with Antisense of Australia
More From BioPortfolio on "TJAB Forms Drug Development JV with Antisense of Australia"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
